Effect of coronaviruses on blood vessel permeability: potential therapeutic targets

NR Machado, KT Dias, BFS Cortes… - Therapeutic …, 2023 - journals.sagepub.com
Coronavirus-induced diseases have afflicted humanity for several decades. This scenario
was aggravated by the emergence of the coronavirus disease 2019 (named COVID-19) in …

Pulmonary vascular system: A vulnerable target for COVID‐19

J Ai, W Hong, M Wu, X Wei - MedComm, 2021 - Wiley Online Library
The number of coronavirus disease 2019 (COVID‐19) cases has been increasing
significantly, and the disease has evolved into a global pandemic, posing an unprecedented …

Elevated cytokine levels in plasma of patients with SARS-CoV-2 do not contribute to pulmonary microvascular endothelial permeability

A Kovacs-Kasa, AA Zaied, S Leanhart… - Microbiology …, 2022 - Am Soc Microbiol
The vascular endothelial injury occurs in severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infections, but the mechanisms are poorly understood. We sought to …

Novel insights on the pulmonary vascular consequences of COVID-19

F Potus, V Mai, M Lebret, S Malenfant… - … of Physiology-Lung …, 2020 - journals.physiology.org
In the last few months, the number of cases of a new coronavirus-related disease (COVID-
19) rose exponentially, reaching the status of a pandemic. Interestingly, early imaging …

Pulmonary endothelial dysfunction and thrombotic complications in patients with COVID-19

C Rodríguez, N Luque, I Blanco… - American journal of …, 2021 - atsjournals.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a new strain of a
Coronaviridae virus that presents 79% genetic similarity to the severe acute respiratory …

Importance of the evaluation of systemic microvascular flow and reactivity in critically ill patients with coronavirus disease 2019—COVID-19

E Tibirica, A De Lorenzo - Microvascular research, 2020 - Elsevier
Amidst the pandemic that has mesmerized the entire world, as it has not spared anyone
according to any specific characteristic, some conditions have, in fact, emerged as risk …

Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies

S Xu, I Ilyas, J Weng - Acta Pharmacologica Sinica, 2023 - nature.com
The fight against coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection is
still raging. However, the pathophysiology of acute and post-acute manifestations of COVID …

Endothelial dysfunction in COVID-19: a unifying mechanism and a potential therapeutic target

P Ambrosino, IL Calcaterra, M Mosella, R Formisano… - Biomedicines, 2022 - mdpi.com
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) generated a
worldwide emergency, until the declaration of the pandemic in March 2020. SARS-CoV-2 …

Mechanisms of Pulmonary Vasculopathy in Acute and Long-Term COVID-19: A Review

M Riou, F Coste, A Meyer, I Enache, S Talha… - International Journal of …, 2024 - mdpi.com
Despite the end of the pandemic, coronavirus disease 2019 (COVID-19) remains a major
public health concern. The first waves of the virus led to a better understanding of its …

[HTML][HTML] The cross-talk of lung and heart complications in COVID-19: Endothelial cells dysfunction, thrombosis, and treatment

L Liu, H Jing, X Wu, M Xiang, VA Novakovic… - Frontiers in …, 2022 - frontiersin.org
The pandemic respiratory illness SARS-CoV-2 has increasingly been shown to be a
systemic disease that can also have profound impacts on the cardiovascular system …